Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 8, 2015, Pages 1537-1546

  Dief, A E ^a   Mostafa, D K ^a   Sharara, G M ^a   Zeitoun, T H ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Arthritis; ATB 346; Hydrogen sulfide; Inflammatory markers; Naproxen; Zymosan

Indexed keywords

ATB 346; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NAPROXEN; NAPROXEN DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BLOOD; CELL COUNT; CHONDROPROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GAIT DISORDER; HISTOPATHOLOGY; INFLAMMATION; JOINT EFFUSION; JOINT SWELLING; KNEE PAIN; LEUKOCYTE ADHERENCE; MALE; NEUTROPHIL; NONHUMAN; PAIN ASSESSMENT; RAT; ANIMAL; ARTHRITIS, EXPERIMENTAL; CHEMICALLY INDUCED; DRUG EFFECTS; INTRAARTICULAR DRUG ADMINISTRATION; PAIN; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; HYDROGEN SULFIDE; INJECTIONS, INTRA-ARTICULAR; MALE; NAPROXEN; NEUTROPHILS; PAIN; RATS; RATS, WISTAR; ZYMOSAN;

EID: 84942244765     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. FUJIWARA N, KOBAYASHI K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 281-286.
2. WHITEMAN M, WINYARD PG. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol 2011; 4: 13-32.
3. PENIDO C, CONTE FP, CHAGAS MS, RODRIGUES CA, PEREIRA JF, HENRIQUES MG. Antiinflammatory effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on zymosan induced arthritis in mice. Inflamm Res 2006; 55: 457-464.
4. LI L, HSU A, MOORE PK. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation- a tale of three gases. Pharmacol Ther 2009; 123: 386-400.
5. SIDHAPURIWALA JN, NG SW, BHATIA M. Effects of hydrogen sulfide on inflammation in caerulein-induced acute pancreatitis. J Inflamm (Lond) 2009; 6: 35.
6. ENG A, RAMASAM T, BHATIA M. Hydrogen sulfide. Pancreapedia (DOI: 10.3998/panc.2011.18]
7. ZHANG J, SIO SW, MOOCHHALA S, BHATIA M. Role of hydrogen sulfide in severe burn injury-induced inflammation in mice. Mol Med 2010; 16: 417-424.
8. WALLACE JL, VONG L, MCKNIGHT W, DICAY M, MARTIN GR. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterol 2009; 137: 569-578.
9. TAMIZHSELVI R, KOH YH, SUN J, ZHANG H, BHATIA M. Hydrogen sulfide induces ICAM-1 expression and neutrophil adhesion to caerulein-treated pancreatic acinar cells through NF-kappaB and Src-family kinases pathway. Exp Cell Res 2010; 316: 1625-1636.
10. ZANARDO RC, BRANCALEONE V, DISTRUTTI E, FIORUCCI S, CIRINO G, WALLACE JL. Hydrogen sulfide is an endogenous modulator of leukocyte mediated inflammation. FASEB J 2006; 20: 2118-2120.
11. LI L, ROSSONI G, SPARATORE A, LEE LC, DEL SOLDATO P, MOORE PK. Anti inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 2007; 42: 706-719.
12. TAKAHASHI T, MUNETA T, TSUJI K, SEKIYA I. BMP-7 inhibits cartilage degeneration through suppression of inflammation in rat zymosan-induced arthritis. Cell Tissue Res 2011; 344: 321-332.
13. CICALA C1, IANARO A, FIORUCCI S, CALIGNANO A, BUCCI M, GERLI R, SANTUCCI L, WALLACE JL, CIRINO G. NOnaproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 2000; 130: 1399-1405.
14. YU YC, KOO ST, KIM CH, LYU Y, GRADY JJ, CHUNG JM. Two variables that can be used as pain indices in experimental animal models of arthritis. J Neurosci Methods 2002; 115: 107-113.
15. PARK HJ, LEE Y, LEE J, PARK C, MOON DE. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anesth 2006; 53: 470-477.
16. EKUNDI-VALENTIM E, SANTOS KT, CAMARGO EA, DENADAISOUZA A, TEIXEIRA SA, ZANONI CI, GRANT AD, WALLACE JL, MUSCARÁ MN, COSTAL SK. Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. Br J Pharmacol 2010; 159: 1463-1474.
17. MCGREGOR RR, SPAGNUOLO PJ, LENTENCK AL. inhibition of granulocyte adherence by ethanol, prednisone and aspirin, measured with an assay system. N Engl J Med 1974; 26: 642-646.
18. RODRIGUEZ AB, PARIENTE AJ, PRIETO P, BARRIGA C. Effect of cefmetazole, cefositin and imipenem on polymorphonuclear leukocytes. Gen Pharmacol 1987; 18: 613-615.
19. CHAVES HV, RIBEIRO RDE A, DE SOUZA AM, RODRIGUES E SILVA AA, GOMES AS, VALE ML, BEZERRA MM, BRITO GA. Experimental model of zymosan-induced arthritis in the rat temporomandibular joint: role of nitric oxide and neutrophils. J Biomed Biotechnol 2011; 2011: 707985.
20. LI L, BHATIA M, ZHU YZ, ZHU YC, RAMNATH RD, WANG ZJ, ANUAR FB, WHITEMAN M, SALTO-TELLEZ M, MOORE PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005; 19: 1196-1198.
21. STOLINA M, SCHETT G, DWYER D, VONDERFECHT S, MIDDLETON S, DURYEA D, PACHECO E, VAN G, BOLON B, FEIGE U, ZACK D, KOSTENUIK P. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNF alpha or anti-IL-1 therapies. Arthritis Res Ther 2009; 11: R187-R202.
22. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
23. VANCUROVA I, MISKOLCI V, DAVIDSON D. NF-kB Activation in Tumor Necrosis Factor a-stimulated neutrophils is mediated by protein kinase C ™. J Biol Chem 2001; 267: 19746-19752.
24. BERS G, GARFIN D. Protein and nucleic acid blotting and immunobiochemical detection. BioTechniques 1985; 3: 276-288.
25. KASHFI K, OLSON KR. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide releasing chimeras. Biochem Pharmacol 2013; 85: 689-703.
26. FIORUCCI S1, ANTONELLI E, DISTRUTTI E, DI SANTE M, MORELLI A, CIRINO G, WALLACE JL. Inhibition of hydrogen sulfide generation contributes to the gastric injury caused by anti-inflammatory non steroidal drugs. Gastroenterology 2005: 129: 1210-1224.
27. MAEDA Y, AOKI Y, SEKIGUCHI F, MATSUNAMI M, TAKAHASHI T, NISHIKAWA H, KAWABATA A. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels. Pain 2009; 142: 127-132.
28. ANDRUSKI B, MCCAFFERTY DM, IGNACY T, MILLEN B, MCDOUGALL JJ. Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis. Am J Physiol Regul Integr Comp Physiol 2008; 295: R814-20.
29. ROITT I. Introduction to the immune system. In: Roitt I, Brostoff J, (eds) Immunology, 6th ed. St. Louis: Mosby, 2001; pp. 1-26.
30. NEUGEBAUER V, HAN JS, ADWANIKAR H, FU Y, JI G. Techniques for assessing knee joint pain in arthritis. Mol Pain 2007; 3: 8.
31. HAUSER RA. The acceleration of articular cartilage degeneration in osteoarthritis by nonsteroidal anti- inflammatory drugs. J Prolotherapy 2010; 1: 305-322.
32. LI L, FOX B, KEEBLE J, SALTO-TELLEZ M, WINYARD PG, WOOD ME, MOORE PK, WHITEMAN M. The complex effects of the slow releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. J Cell Mol Med 2013; 17: 365-376.
33. ROCHA FA, SILVA FS JR, LEITE AC, LEITE AK, GIRÃO VC, CASTRO RR, CUNHA FQ. Tadalafil analgesia in experimental arthritis involves suppression of intraarticular TNF release. Br J Pharmacol 2011; 164: 828-835.
34. COLLINS T, READ MA, NEISH AS, WHITLEY MZ, THANOS D, MANIATIS T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 9: 899-909.
35. LEE HS. LEE CH. Tsai HC. Salter DM. Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL- 1beta. Osteoarthritis Cartilage 2009; 17: 91-99.
36. STUHLMEIER KM, BRÖLL J, ILIEV B. NF-kappaB independent activation of a series of proinflammatory genes by hydrogen sulphide. Exp Biol Med (Maywood) 2009; 234: 1327-1338.
37. ZHANG H, ZHI L, MOORE PK, BHATIA M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1193-1201.
38. ZHANG H, ZHI L, MOOCHHALA S, MOORE PK, BHATIA M. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2007; 292: L960-971.
39. BHATIA M. Role of hydrogen sulfide in the pathology of inflammation. Scientifica (Cairo) 2012; 159680.
40. MARTELLI A, TESTAI L, BRESCHI MC, BLANDIZZI C, VIRDIS A, TADDEI S, CALDERONE V. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 2012; 32: 1093-1130.
41. WALLACE JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 2007; 28: 501-505.
42. WHITEMAN M, LI L, ROSE P, TAN CH, PARKINSON DB, MOORE PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 2010; 12: 1147-1154.
43. DUFTON N, NATIVIDAD J, VERDU EF, WALLACE JL. Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe. Sci Rep 2012; 2: 499.